| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 27.008 | 39.219 | 48.903 | 45.477 | 47.852 | 54.544 | 134.109 | 217.260 |
| Total Income - EUR | - | - | 27.100 | 39.219 | 48.903 | 45.479 | 47.948 | 54.547 | 134.116 | 217.282 |
| Total Expenses - EUR | - | - | 13.088 | 18.471 | 21.029 | 27.064 | 28.927 | 18.293 | 42.759 | 52.047 |
| Gross Profit/Loss - EUR | - | - | 14.012 | 20.748 | 27.874 | 18.415 | 19.022 | 36.254 | 91.357 | 165.235 |
| Net Profit/Loss - EUR | - | - | 13.409 | 20.360 | 27.385 | 17.979 | 18.542 | 35.708 | 90.016 | 158.717 |
| Employees | - | - | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
Check the financial reports for the company - Helianthus Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 4.196 | 4.385 | 2.786 | 3.685 | 2.961 | 3.095 | 17.347 | 17.362 |
| Current Assets | - | - | 24.218 | 38.722 | 87.647 | 97.481 | 46.386 | 45.229 | 91.496 | 146.731 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 12.879 | 12.812 | 44.551 | 39.527 | 409 | 26.545 | 57.523 | 120.023 |
| Cash | - | - | 11.339 | 25.911 | 43.096 | 57.954 | 45.977 | 18.684 | 33.973 | 26.708 |
| Shareholders Funds | - | - | 13.452 | 33.565 | 60.300 | 77.136 | 33.322 | 35.749 | 90.056 | 158.757 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 14.962 | 9.542 | 30.133 | 24.029 | 16.025 | 12.575 | 18.788 | 5.336 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Helianthus Medical Srl